Collegium Pharma (COLL) Posts Q1 Loss of $0.29/Sh

Collegium Pharma (NASDAQ: COLL) reported Q1 EPS of ($0.29), which may not compare to the analyst estimate of ($0.24). Revenue for the quarter came in at $74.5 million versus the consensus estimate of $70.82 million.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Black Rock Coffee Bar, Inc. (BRCB) Misses Q2 EPS by 1c
• Optex Systems Holdings, Inc. (OPXS) Misses Q3 EPS by 2c